Stefano Persiani
Impact in
- Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 16
- Inflammatory mediators and NSAID effects 8
- Pharmacogenetics and Drug Metabolism 5
- Berberine and alkaloids research 4
- Drug-Induced Hepatotoxicity and Protection 4
-
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Lucio C. Rovati (24 shared papers)Aldo Roda (6 shared papers)Marcello Locatelli (4 shared papers)Giampaolo Giacovelli (6 shared papers)E. Roda (1 shared paper)M. Strolin Benedetti (10 shared papers)Stefan Lohmander (2 shared papers)Yves Henrotin (2 shared papers)
- Journals
- Osteoarthritis and Cartilage (5 papers)Journal of Chromatography B (3 papers)Biopharmaceutics & Drug Disposition (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Stefano Persiani
55 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 107
- Rheumatology 449
- Pharmacology 247
- Equine 18
- Pharmacology 65
- Biochemistry 31
Countries citing papers authored by Stefano Persiani
This map shows the geographic impact of Stefano Persiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Persiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Persiani more than expected).
Fields of papers citing papers by Stefano Persiani
This network shows the impact of papers produced by Stefano Persiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Persiani. The network helps show where Stefano Persiani may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefano Persiani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 252 | |
| 2 | 2005 | 137 | |
| 3 | 2007 | 119 | |
| 4 | 2015 | 67 | |
| 5 | 2006 | 54 | |
| 6 | 2012 | 50 | |
| 7 | 1995 | 36 | |
| 8 | 2018 | 32 | |
| 9 | 1997 | 26 | |
| 10 | 1996 | 24 | |
| 11 | 1991 | 23 | |
| 12 | 2007 | 23 | |
| 13 | 2013 | 21 | |
| 14 | 1994 | 21 | |
| 15 | 2000 | 20 | |
| 16 | 2009 | 20 | |
| 17 | 1990 | 19 | |
| 18 | 1997 | 17 | |
| 19 | 2016 | 16 | |
| 20 | 2002 | 16 |
About Stefano Persiani
Stefano Persiani is a scholar working on Pharmacology, Pharmacology, Molecular Biology, Oncology and Cellular and Molecular Neuroscience, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (8 papers), Inflammatory mediators and NSAID effects (8 papers), Neuropeptides and Animal Physiology (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Berberine and alkaloids research (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Rheumatology (449 citations), Pharmacology (247 citations), Equine (18 citations), Pharmacology (65 citations) and Biochemistry (31 citations). Stefano Persiani has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Lucio C. Rovati, Aldo Roda, Marcello Locatelli, Giampaolo Giacovelli, E. Roda, M. Strolin Benedetti, Stefan Lohmander, Yves Henrotin, Virginia B. Kraus and Roberto Rotini. Their work appears in journals such as Osteoarthritis and Cartilage, Journal of Chromatography B, Biopharmaceutics & Drug Disposition, Cancer Chemotherapy and Pharmacology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.